On November 8th, 2023, the FDA approved Eli Lilly and Co.’s new weight loss drug, Zepbound. This approval comes amid a growing shortage of semaglutide-based drugs, such as Ozempic and Wegovy, which are commonly prescribed “off-label” for... Read More
Author: Antony B. Kamel, Esq.
In a recent advisory opinion, the United States Department of Health and Human Services Office of Inspector General (the “OIG”) appears to reaffirm its previous findings concerning the compliance of certain practices by online healthcare... Read More
Part II: Proposed New York Law Would Require Certain Health Care Transactions to be Approved by the New York Department of Health
Previously, we outlined New York Governor Kathy Hochul’s proposed 2023-2024 New York State Budget (“Proposed Budget”) and how it may impact the healthcare deal landscape in New York. Specifically, we discussed proposed amendments to Part L of... Read More
In the rapidly evolving landscape of healthcare, small and medium-sized home healthcare providers play a crucial role in delivering quality care to individuals in need. As home healthcare continues to provide better access, improve outcomes and save... Read More
Proposed New York Law Would Require Certain Health Care Transactions to be Approved by the New York Department of Health
Recently, New York Governor Kathy Hochul unveiled the 2023-2024 budget for New York State (the “Budget”), including an amendment to Part L of the Health and Mental Hygiene Article VII (the “Proposed Legislation”). The Proposed Legislation... Read More
Antitrust | Articles | Buying and Selling Medical Practices including Private Equity Transactions | Healthcare Private Equity Services | Hospital/Physician Negotiations and Joint Ventures | Management Services Organizations (MSO) | Medical Practice Mergers & Super Groups | Private Equity Investing | Private Equity Investing in Specialty Pharmacy & Pharmaceutical Companies
FTC Proposes New Rule to Ban Non-Compete Agreements: What does this mean for employers and employees?
On January 5, 2023, the Federal Trade Commission (“FTC”) issued a Notice of Proposed Rulemaking (the “Notice”) containing a proposed rule (“Rule”) that would restrict employers from entering into and/or enforcing non-compete agreements... Read More
Effective as of November 16, 2022, certain health care entities must continue to employ certain employees for a period of four months following a change in control of such entity. On August 18, 2022, New Jersey Governor Phil Murphy signed Public... Read More